Platt OS - Search Results

1

Pain in sickle cell disease. Rates and risk factors.

Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR. Platt OS, et al. N Engl J Med. 1991 Jul 4;325(1):11-6. doi: 10.1056/NEJM199107043250103. N Engl J Med. 1991. PMID: 1710777 Free article.

2

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Platt OS, et al. N Engl J Med. 1994 Jun 9;330(23):1639-44. doi: 10.1056/NEJM199406093302303. N Engl J Med. 1994. PMID: 7993409 Free article.

3

Pulmonary hypertension and nitric oxide depletion in sickle cell disease.

Bunn HF, Nathan DG, Dover GJ, Hebbel RP, Platt OS, Rosse WF, Ware RE. Bunn HF, et al. Among authors: platt os. Blood. 2010 Aug 5;116(5):687-92. doi: 10.1182/blood-2010-02-268193. Epub 2010 Apr 15. Blood. 2010. PMID: 20395414 Free article. Review.

4

The association between hydroxyurea treatment and pain intensity, analgesic use, and utilization in ambulatory sickle cell anemia patients.

Smith WR, Ballas SK, McCarthy WF, Bauserman RL, Swerdlow PS, Steinberg MH, Waclawiw MA; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Smith WR, et al. Pain Med. 2011 May;12(5):697-705. doi: 10.1111/j.1526-4637.2011.01096.x. Epub 2011 Apr 11. Pain Med. 2011. PMID: 21481164 Free PMC article. Clinical Trial.

5

Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease.

Kinney TR, Sleeper LA, Wang WC, Zimmerman RA, Pegelow CH, Ohene-Frempong K, Wethers DL, Bello JA, Vichinsky EP, Moser FG, Gallagher DM, DeBaun MR, Platt OS, Miller ST. Kinney TR, et al. Among authors: platt os. Pediatrics. 1999 Mar;103(3):640-5. doi: 10.1542/peds.103.3.640. Pediatrics. 1999. PMID: 10049969

6

Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group.

Kinney TR, Helms RW, O'Branski EE, Ohene-Frempong K, Wang W, Daeschner C, Vichinsky E, Redding-Lallinger R, Gee B, Platt OS, Ware RE. Kinney TR, et al. Among authors: platt os. Blood. 1999 Sep 1;94(5):1550-4. Blood. 1999. PMID: 10477679 Free article. Clinical Trial.

7

Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia.

Charache S, Dover GJ, Moore RD, Eckert S, Ballas SK, Koshy M, Milner PF, Orringer EP, Phillips G Jr, Platt OS, et al. Charache S, et al. Among authors: platt os. Blood. 1992 May 15;79(10):2555-65. Blood. 1992. PMID: 1375104 Free article. Clinical Trial.

8

Preventing stroke in sickle cell anemia.

Platt OS. Platt OS. N Engl J Med. 2005 Dec 29;353(26):2743-5. doi: 10.1056/NEJMp058274. N Engl J Med. 2005. PMID: 16382060 No abstract available.

9

Hydroxyurea for the treatment of sickle cell anemia.

Platt OS. Platt OS. N Engl J Med. 2008 Mar 27;358(13):1362-9. doi: 10.1056/NEJMct0708272. N Engl J Med. 2008. PMID: 18367739 Review. No abstract available.

10

Climatic and geographic temporal patterns of pain in the Multicenter Study of Hydroxyurea.

Smith WR, Bauserman RL, Ballas SK, McCarthy WF, Steinberg MH, Swerdlow PS, Waclawiw MA, Barton BA; Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Smith WR, et al. Pain. 2009 Nov;146(1-2):91-8. doi: 10.1016/j.pain.2009.07.008. Epub 2009 Aug 14. Pain. 2009. PMID: 19683393

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page